Data Integrity issues, Delayed records:
USFDA had inspected the Jiangsu Hengrui Pharma’s Huanghe road site in January 2024. The site
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
